By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Siemens Medical Solutions Diagnostics (Berkeley, CA) 

P.O. Box 2466

Berkeley  California  94702-0466  U.S.A.
Phone: n/a Fax: 510-705-5865

Over the past 50 years, Bayer Healthcare, Diagnostics has been revolutionizing the commercialization of biotechnology products and diagnostic systems. One of the largest diagnostic businesses in the world, Bayer Diagnostics has compiled an extensive history of technological firsts, including setting new diagnostic standards in diabetes and introducing the world's first automated instrument for clinical chemistry. The organization supports customers in 100 countries through an extensive portfolio of central, self-testing, nucleic acid and near patient care diagnostics systems and services for use in the assessment and management of health, including the areas of cardiovascular and kidney disease, oncology, virology, women's health and diabetes.

Bayer Healthcare, Diagnostics' global headquarters in the United States operates as part of Bayer HealthCare LLC, a member of the worldwide Bayer HealthCare group. With an annual R&D investment of over two hundred million dollars from its parent company, and approximately 7,000 employees, Bayer Diagnostics is equipped to become the leader in diagnostic technology.

Nucleic Acid Diagnostics Business Segment

Bayer Nucleic Acid Diagnostics (NAD) offers an innovative line of molecular assays and instrumentation. Dedicated to the constant incorporation of new ideas and development of disease-specific tests, Bayer's NAD assays utilize technologies of bDNA, TMA™, and PCR, to name a few. Strengthened by the acquisition of Chiron Diagnostics in 1998, Bayer Diagnostics continues to expand its innovate edge with a portfolio that now includes molecular diagnostic technology capable of benefiting the millions of patients with hepatitis and human immunodeficiency virus (HIV).

Last Updated: 01-19-07

Key Statistics

Ownership: Subsidiary

Web Site: Siemens Medical Solutions Diagnostics (Berkeley, CA)
Symbol: SI


Company News
Siemens Medical Solutions Diagnostics (Tarrytown, NY) Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu Third-Generation TRAb Assay Delivers Unprecedented Specificity for Diagnosing Graves' Disease 12/17/2007 8:32:58 AM
Celera Genomics Group-an Applera Corp. Business (CRA) Grants Real Time PCR License to Siemens Medical Solutions Diagnostics (Berkeley, CA) (SI) 10/1/2007 10:15:29 AM
Siemens Medical Solutions Announces World-Wide Availability of the ADVIA 1800 Chemistry System 7/17/2007 12:12:26 PM
Siemens Medical Solutions Unveils New Solutions to Improve Laboratory Workflow at the American Association for Clinical Chemistry Conference 7/16/2007 11:33:18 AM
Bayer Healthcare, Diagnostics (Tarrytown, NY) Expands Availability Of High Sensitivity And High Precision Troponin Assay For Use On ADVIA Centaur(R) CP Immunoassay System 8/10/2006 12:04:36 PM
Bayer Healthcare, Diagnostics (Tarrytown, NY) Receives FDA Approval For First Fully-Automated Human Immunodeficiency Virus (HIV) Antibody Test 6/21/2006 10:25:57 AM
Bayer Healthcare, Biological Products (CA) (BAY) Release: Serum HER-2/Neu Change Predicts Clinical Outcome To Trastuzumab-Based Therapy 6/5/2006 12:30:29 PM
Bayer HealthCare AG (BAY) Acquires Bayer Healthcare, Biological Products (CA) (BAY)'s TrueClone(TM) cDNAs For Functional Analyses 3/13/2006 11:51:54 AM
Bayer Pharmaceuticals Corporation (CT) Release: Aspirin Unsurpassed In Prevention Of Heart Attack And Stroke In Wide Range Of Patients 3/13/2006 10:46:16 AM
Signet Laboratories, Inc. Announces License Agreement With Bayer Diagnostics For Urinary Trypsin Inhibitor Immunoassays To Further Research Inflammatory Disease 3/1/2006 10:57:31 AM